Published in Mol Cell on December 11, 2009
Deep mutational scanning: a new style of protein science. Nat Methods (2014) 2.05
A de novo protein binding pair by computational design and directed evolution. Mol Cell (2011) 1.65
An in vivo platform for identifying inhibitors of protein aggregation. Nat Chem Biol (2015) 1.53
Genetic selection designed to stabilize proteins uncovers a chaperone called Spy. Nat Struct Mol Biol (2011) 1.52
A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function. Proc Natl Acad Sci U S A (2012) 1.39
A method for multiplex gene synthesis employing error correction based on expression. PLoS One (2015) 1.38
Strain engineering for improved expression of recombinant proteins in bacteria. Microb Cell Fact (2011) 1.36
Protein folding in the cell: challenges and progress. Curr Opin Struct Biol (2010) 1.32
Rapid profiling of disease alleles using a tunable reporter of protein misfolding. Genetics (2012) 1.20
Ribosomal history reveals origins of modern protein synthesis. PLoS One (2012) 1.19
Frustration in biomolecules. Q Rev Biophys (2014) 1.05
Perturbing the folding energy landscape of the bacterial immunity protein Im7 by site-specific N-linked glycosylation. Proc Natl Acad Sci U S A (2010) 1.00
Protein stability by number: high-throughput and statistical approaches to one of protein science's most difficult problems. Curr Opin Chem Biol (2011) 0.98
Deep sequencing of systematic combinatorial libraries reveals β-lactamase sequence constraints at high resolution. J Mol Biol (2012) 0.96
In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells. PLoS One (2011) 0.89
Conformational properties of the unfolded state of Im7 in nondenaturing conditions. J Mol Biol (2011) 0.89
Super Spy variants implicate flexibility in chaperone action. Elife (2014) 0.89
Non-allosteric enzyme switches possess larger effector-induced changes in thermodynamic stability than their non-switch analogs. Protein Sci (2013) 0.86
Increasing protein stability: importance of DeltaC(p) and the denatured state. Protein Sci (2010) 0.85
In vivo detection and quantification of chemicals that enhance protein stability. Anal Biochem (2012) 0.84
Understanding the folding-function tradeoff in proteins. PLoS One (2013) 0.83
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process. Protein Eng Des Sel (2015) 0.79
Repurposing a bacterial quality control mechanism to enhance enzyme production in living cells. J Mol Biol (2015) 0.78
Directed evolution of human heavy chain variable domain (VH) using in vivo protein fitness filter. PLoS One (2014) 0.78
A "fuzzy"-logic language for encoding multiple physical traits in biomolecules. J Mol Biol (2014) 0.78
Genetic selection for enhanced folding in vivo targets the Cys14-Cys38 disulfide bond in bovine pancreatic trypsin inhibitor. Antioxid Redox Signal (2011) 0.76
Evolving protein stability through genetic selection. Mol Cell (2009) 0.76
Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells. Korean J Chem Eng (2012) 0.76
Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs. J Biol Chem (2017) 0.76
The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention. Clin Epigenetics (2011) 0.75
High-throughput identification of protein mutant stability computed from a double mutant fitness landscape. Protein Sci (2015) 0.75
Cytosolic selection systems to study protein stability. J Bacteriol (2014) 0.75
SPY-ing into Protein Stability. Indian J Microbiol (2011) 0.75
Protein aggregation: A rescue by chaperones. Nat Chem Biol (2016) 0.75
Optimization of expression and purification of HSPA6 protein from Camelus dromedarius in E. coli. Saudi J Biol Sci (2015) 0.75
Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Sci Rep (2017) 0.75
Folding Optimization In Vivo Uncovers New Chaperones. J Mol Biol (2015) 0.75
Computational tools help improve protein stability but with a solubility tradeoff. J Biol Chem (2017) 0.75
Protein stability promotes evolvability. Proc Natl Acad Sci U S A (2006) 5.73
Missense meanderings in sequence space: a biophysical view of protein evolution. Nat Rev Genet (2005) 4.67
Im7 folding mechanism: misfolding on a path to the native state. Nat Struct Biol (2002) 3.15
Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat Biotechnol (2002) 2.87
Why are proteins marginally stable? Proteins (2002) 2.74
The structural stability of a protein is an important determinant of its proteolytic susceptibility in Escherichia coli. J Biol Chem (1989) 2.54
Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol (2006) 2.45
Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling. Proc Natl Acad Sci U S A (2003) 2.43
How protein stability and new functions trade off. PLoS Comput Biol (2008) 2.41
Localizing frustration in native proteins and protein assemblies. Proc Natl Acad Sci U S A (2007) 2.33
Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation. Curr Opin Struct Biol (2007) 2.28
Pulse proteolysis: a simple method for quantitative determination of protein stability and ligand binding. Nat Methods (2005) 2.18
Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. J Mol Biol (1999) 1.97
Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. J Mol Biol (2002) 1.97
The crystal structure of the DNase domain of colicin E7 in complex with its inhibitor Im7 protein. Structure (1999) 1.87
Quantitative protein stability measurement in vivo. Nat Struct Biol (2001) 1.85
Thermodynamics of neutral protein evolution. Genetics (2006) 1.83
Stability and function: two constraints in the evolution of barstar and other proteins. Structure (1994) 1.67
Directed evolution of enzyme stability. Biomol Eng (2005) 1.56
Directed evolution of proteins for heterologous expression and stability. Curr Opin Struct Biol (2005) 1.43
Folding of maltose-binding protein. Evidence for the identity of the rate-determining step in vivo and in vitro. J Biol Chem (1993) 1.37
Extracting function from a beta-trefoil folding motif. Proc Natl Acad Sci U S A (2008) 1.34
Correlation of levels of folded recombinant p53 in escherichia coli with thermodynamic stability in vitro. J Mol Biol (2007) 1.27
Genetic screens and directed evolution for protein solubility. Curr Opin Chem Biol (2003) 1.26
Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol (2006) 1.20
Highly discriminating protein-protein interaction specificities in the context of a conserved binding energy hotspot. J Mol Biol (2004) 1.20
Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 2. Cognate and noncognate interactions that span the millimolar to femtomolar affinity range. Biochemistry (1995) 1.19
Selecting proteins with improved stability by a phage-based method. Nat Biotechnol (1998) 1.10
Thermodynamically stable aggregation-resistant antibody domains through directed evolution. J Mol Biol (2007) 1.09
Point mutations in protein globular domains: contributions from function, stability and misfolding. J Mol Biol (2006) 1.09
FRET-based in vivo screening for protein folding and increased protein stability. J Mol Biol (2003) 1.07
Equilibrium hydrogen exchange reveals extensive hydrogen bonded secondary structure in the on-pathway intermediate of Im7. J Mol Biol (2004) 1.05
Split-ubiquitin and the split-protein sensors: chessman for the endgame. Chembiochem (2008) 1.04
Relating destabilizing regions to known functional sites in proteins. BMC Bioinformatics (2007) 1.02
Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01
Combinatorial approaches to protein stability and structure. Eur J Biochem (2004) 0.99
Active site flexibility in enzyme catalysis. Ann N Y Acad Sci (1998) 0.96
Beta-lactamase: an ideal reporter system for monitoring gene expression in live eukaryotic cells. Biotechniques (2007) 0.89
The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case. J Mol Biol (2008) 0.87
Evolutionary protein stabilization in comparison with computational design. J Mol Biol (2005) 0.85
An activity-independent selection system of thermostable protein variants. Nat Methods (2007) 0.84
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med (2003) 8.93
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study. J Clin Oncol (2013) 3.75
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Pulling geometry defines the mechanical resistance of a beta-sheet protein. Nat Struct Biol (2003) 3.21
Im7 folding mechanism: misfolding on a path to the native state. Nat Struct Biol (2002) 3.15
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A (2008) 2.90
Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol (2006) 2.82
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood (2006) 2.43
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. Blood (2007) 2.38
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood (2012) 2.38
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood (2010) 2.25
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood (2003) 2.23
Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat Struct Biol (2002) 2.21
Snapshots of DsbA in action: detection of proteins in the process of oxidative folding. Science (2004) 2.18
Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem (2009) 2.13
Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J Mol Biol (2005) 2.10
Folding versus aggregation: polypeptide conformations on competing pathways. Arch Biochem Biophys (2007) 1.97
Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood (2002) 1.95
Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins. Protein Sci (2005) 1.91
Oxidative protein folding in bacteria. Mol Microbiol (2002) 1.87
Donor-strand exchange in chaperone-assisted pilus assembly proceeds through a concerted beta strand displacement mechanism. Mol Cell (2006) 1.81
A diversity of assembly mechanisms of a generic amyloid fold. Mol Cell (2011) 1.80
The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma (2009) 1.77
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol (2011) 1.71
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res (2007) 1.70
The Yin and Yang of protein folding. FEBS J (2005) 1.68
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood (2010) 1.67
Catalysis of disulfide bond formation and isomerization in the Escherichia coli periplasm. Biochim Biophys Acta (2004) 1.67
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. J Clin Oncol (2011) 1.66
Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci U S A (2002) 1.66
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response. EMBO J (2011) 1.65
Copper stress causes an in vivo requirement for the Escherichia coli disulfide isomerase DsbC. J Biol Chem (2005) 1.64
Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica (2006) 1.64
Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology (2014) 1.64
The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma. Clin Cancer Res (2011) 1.61
Intermediates: ubiquitous species on folding energy landscapes? Curr Opin Struct Biol (2007) 1.60
Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J Mol Biol (2006) 1.60
Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood (2003) 1.60
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma. Leuk Lymphoma (2010) 1.58
Mechanically unfolding the small, topologically simple protein L. Biophys J (2005) 1.57
In vivo substrate specificity of periplasmic disulfide oxidoreductases. J Biol Chem (2004) 1.56
Overexpression of two different GTPases rescues a null mutation in a heat-induced rRNA methyltransferase. J Bacteriol (2002) 1.56
Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res (2003) 1.53
Structural analysis of the rate-limiting transition states in the folding of Im7 and Im9: similarities and differences in the folding of homologous proteins. J Mol Biol (2003) 1.52
Genetic selection designed to stabilize proteins uncovers a chaperone called Spy. Nat Struct Mol Biol (2011) 1.52
Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Br J Haematol (2009) 1.48
A force-activated trip switch triggers rapid dissociation of a colicin from its immunity protein. PLoS Biol (2013) 1.48
Structural plasticity of an acid-activated chaperone allows promiscuous substrate binding. Proc Natl Acad Sci U S A (2009) 1.46
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood (2008) 1.45
Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. J Mol Biol (2003) 1.44
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin Cancer Res (2011) 1.44
An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms. Nat Struct Mol Biol (2009) 1.43
Dynamics in the unfolded state of beta2-microglobulin studied by NMR. J Mol Biol (2004) 1.41
Mechanically unfolding proteins: the effect of unfolding history and the supramolecular scaffold. Protein Sci (2002) 1.39
Conformational conversion during amyloid formation at atomic resolution. Mol Cell (2011) 1.39
Self-expanding stent implantation in arterial duct during hybrid palliation of hypoplastic left heart syndrome: midterm experience with a specially designed stent. EuroIntervention (2015) 1.39
Hierarchical assembly of beta2-microglobulin amyloid in vitro revealed by atomic force microscopy. J Mol Biol (2003) 1.39
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res (2010) 1.39
Structural insights into the polymorphism of amyloid-like fibrils formed by region 20-29 of amylin revealed by solid-state NMR and X-ray fiber diffraction. J Am Chem Soc (2008) 1.38
The transition state for folding of an outer membrane protein. Proc Natl Acad Sci U S A (2010) 1.37
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood (2010) 1.36
The effect of core destabilization on the mechanical resistance of I27. Biophys J (2002) 1.36
Protein refolding by pH-triggered chaperone binding and release. Proc Natl Acad Sci U S A (2009) 1.35
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood (2013) 1.35
The CXXC motif is more than a redox rheostat. J Biol Chem (2007) 1.35
Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood (2002) 1.34
A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. Biochemistry (2006) 1.33
A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide. Blood (2012) 1.33
pH as a trigger of peptide beta-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc (2003) 1.32
Untangling the unfolded protein response. Cell Cycle (2008) 1.32
The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. EMBO J (2002) 1.31
Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7. Proc Natl Acad Sci U S A (2005) 1.31
Magic angle spinning NMR analysis of beta2-microglobulin amyloid fibrils in two distinct morphologies. J Am Chem Soc (2010) 1.30
Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry. Proc Natl Acad Sci U S A (2010) 1.29
Trapping the on-pathway folding intermediate of Im7 at equilibrium. J Mol Biol (2004) 1.29
An engineered pathway for the formation of protein disulfide bonds. Science (2004) 1.29
A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. J Mol Biol (2003) 1.28
A generic mechanism of beta2-microglobulin amyloid assembly at neutral pH involving a specific proline switch. J Mol Biol (2009) 1.26
The mechanism of folding of Im7 reveals competition between functional and kinetic evolutionary constraints. Nat Struct Mol Biol (2009) 1.26
Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction. Chem Commun (Camb) (2009) 1.24
Direct three-dimensional visualization of membrane disruption by amyloid fibrils. Proc Natl Acad Sci U S A (2012) 1.24
Switching two-state to three-state kinetics in the helical protein Im9 via the optimisation of stabilising non-native interactions by design. J Mol Biol (2004) 1.23
Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation. J Mol Biol (2008) 1.23
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood (2002) 1.22
Reconstitution of a disulfide isomerization system. J Biol Chem (2002) 1.22
Monitoring copopulated conformational states during protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom (2007) 1.22
Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils. J Mol Biol (2009) 1.21
The disulphide isomerase DsbC cooperates with the oxidase DsbA in a DsbD-independent manner. Mol Microbiol (2007) 1.21
Bortezomib (Velcadetrade mark) in the Treatment of Multiple Myeloma. Ther Clin Risk Manag (2006) 1.20
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica (2008) 1.20
Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res (2008) 1.19
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem (2002) 1.18
Intermolecular alignment in β2-microglobulin amyloid fibrils. J Am Chem Soc (2010) 1.18
NMR analysis of the conformational properties of the trapped on-pathway folding intermediate of the bacterial immunity protein Im7. J Mol Biol (2006) 1.17
Tuning the elastic modulus of hydrated collagen fibrils. Biophys J (2009) 1.17
Stacked sets of parallel, in-register beta-strands of beta2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling. J Biol Chem (2010) 1.17
The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res (2003) 1.17